Use of ctDNA for Monitoring of Stage III Colorectal Cancer

Active, not recruitingOBSERVATIONAL

Enrollment

137

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions

Stage III Colorectal Cancer

Trial Locations (1)

University of Pittsburgh Medical Center, Pittsburgh

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Pittsburgh

OTHER

NCT02842203 - Use of ctDNA for Monitoring of Stage III Colorectal Cancer | Biotech Hunter | Biotech Hunter